Envestnet Asset Management’s Exagen XGN Stock Holding History

Envestnet Asset Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,665	Closed	-$64K	–	4085
2022 Q3	$64K	Sell	23,665 -2,463	-9%	-$13.7K	﹤0.01%	3791
2022 Q2	$150K	Buy	26,128 +397	+2%	+$2.31K	﹤0.01%	3694
2022 Q1	$207K	Buy	25,731 +1,839	+8%	+$15.9K	﹤0.01%	3666
2021 Q4	$278K	Sell	23,892 -2,451	-9%	-$28.7K	﹤0.01%	3467
2021 Q3	$358K	Sell	26,343 -2,145	-8%	-$28.5K	﹤0.01%	3188
2021 Q2	$427K	Sell	28,488 -1,129	-4%	-$17.3K	﹤0.01%	3079
2021 Q1	$518K	Buy	+29,617	New	+$528K	﹤0.01%	2825

Other funds holding XGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Envestnet Asset Management's XGN Position: Q4 2022 in Review

Envestnet Asset Management sold out of Exagen (XGN) in Q4 2022, closing a stake of 23,665 shares — an estimated $64K sold.

Envestnet Asset Management first reported a position in XGN in Q1 2021 and held it in 7 quarters. The position peaked at $518K in Q1 2021. 31 funds tracked by Wall St. Rank hold XGN as of Q4 2022.

Envestnet Asset Management reported no remaining Exagen position as of Q4 2022 after selling out during the quarter.
Envestnet Asset Management sold 23,665 Exagen shares in Q4 2022, an estimated $64K.
Envestnet Asset Management first reported a position in Exagen in Q1 2021 and held it in 7 quarters.
Envestnet Asset Management's Exagen position peaked at $518K in Q1 2021.
31 funds tracked by Wall St. Rank held Exagen as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.